论文部分内容阅读
目的了解美沙酮维持治疗人群病毒性肝炎、梅毒、HIV感染状况,为有针对性地开展预防控制工作提供科学依据。方法 2015年2月至2016年2月三门峡市MMT门诊接受美沙酮维持治疗的服药人员为研究对象,检测抗-HCV、梅毒抗体、HIV抗体水平并对结果进行分析。结果本组303例接受美沙酮维持治疗的吸毒人员以男性为主。检测结果均阴性的253例,存在阳性者50例,合并2种及以上感染者5人。抗-HCV阳性率为14.9%;梅毒抗体检初筛TP-ELISA阳性率为3.3%;HIV抗体检测阳性0人。结论接受美沙酮维持治疗的门诊受治者HCV、梅毒感染率和重叠感染率均较高,说明美沙酮维持治疗的覆盖人群是降低危害和重点干预的对象。
Objective To understand the status of viral hepatitis, syphilis and HIV infection in methadone maintenance treatment and to provide a scientific basis for targeted prevention and control. Methods From February 2015 to February 2016, patients taking methadone maintenance treatment at the MMT clinic in Sanmenxia City were enrolled. The anti-HCV, syphilis antibody and HIV antibody levels were detected and the results were analyzed. Results The group of 303 drug abusers receiving methadone maintenance treatment were mainly male. Negative 253 cases of test results, the presence of positive in 50 cases, with two or more infected in 5. The positive rate of anti-HCV was 14.9%. The positive rate of TP-ELISA for primary screening of syphilis was 3.3%. The positive rate of HIV antibody was 0. Conclusions Outpatients receiving methadone maintenance treatment have a higher prevalence of HCV, syphilis and overlap infection, indicating that the coverage of methadone maintenance treatment is the target of harm reduction and key intervention.